Global and Region Transthyretin Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Transthyretin market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Transthyretinmarket, defines the market attractiveness level of Transthyretin market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Transthyretin industry, describes the types of Transthyretin market, the applications of major players and the market size, and deeply analyzes the current situation of the global Transthyretin market and the development prospects and opportunities of Transthyretin industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Transthyretin market in Chapter 13.

    By Player:

    • Ionis Pharmaceuticals Inc

    • Regeneron Pharmaceuticals Inc

    • Arcturus Therapeutics Inc

    • Prothena Corp Plc

    • Alnylam Pharmaceuticals Inc

    • Neurimmune Holding AG

    • Pfizer Inc

    By Type:

    • AG-10

    • ALN-TTRsc02

    • CRX-1008

    • EDE-1307

    • Others

    By End-User:

    • Familial Amyloid Neuropathies

    • Alzheimer's Disease

    • Cardomyopathy

    • Neuropathy

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Transthyretin Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Transthyretin Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Transthyretin Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Transthyretin Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Transthyretin Market Analysis and Outlook to 2022

    • 7.1 Global Transthyretin Consumption (2017-2022)

    • 7.2 United States Transthyretin Consumption (2017-2022)

    • 7.3 Europe Transthyretin Consumption (2017-2022)

    • 7.4 China Transthyretin Consumption (2017-2022)

    • 7.5 Japan Transthyretin Consumption (2017-2022)

    • 7.6 India Transthyretin Consumption (2017-2022)

    • 7.7 South Korea Transthyretin Consumption (2017-2022)

    8 Region and Country-wise Transthyretin Market Analysis and Outlook to 2028

    • 8.1 Global Transthyretin Consumption Forecast (2022-2028)

    • 8.2 United States Transthyretin Consumption Forecast (2022-2028)

    • 8.3 Europe Transthyretin Consumption Forecast (2022-2028)

    • 8.4 China Transthyretin Consumption Forecast (2022-2028)

    • 8.5 Japan Transthyretin Consumption Forecast (2022-2028)

    • 8.6 India Transthyretin Consumption Forecast (2022-2028)

    • 8.7 South Korea Transthyretin Consumption Forecast (2022-2028)

    9 Global Transthyretin Market Outlook by Types and Applications to 2022

    • 9.1 Global Transthyretin Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global AG-10 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global ALN-TTRsc02 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global CRX-1008 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global EDE-1307 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Transthyretin Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Familial Amyloid Neuropathies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardomyopathy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Neuropathy Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Transthyretin Market Outlook by Types and Applications to 2028

    • 10.1 Global Transthyretin Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global AG-10 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global ALN-TTRsc02 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global CRX-1008 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global EDE-1307 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Transthyretin Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Familial Amyloid Neuropathies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cardomyopathy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Neuropathy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Transthyretin Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Transthyretin Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Transthyretin Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Transthyretin Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Transthyretin Market Competitive Analysis

    • 14.1 Ionis Pharmaceuticals Inc

      • 14.1.1 Ionis Pharmaceuticals Inc Company Details

      • 14.1.2 Ionis Pharmaceuticals Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Ionis Pharmaceuticals Inc Transthyretin Product and Service

    • 14.2 Regeneron Pharmaceuticals Inc

      • 14.2.1 Regeneron Pharmaceuticals Inc Company Details

      • 14.2.2 Regeneron Pharmaceuticals Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Regeneron Pharmaceuticals Inc Transthyretin Product and Service

    • 14.3 Arcturus Therapeutics Inc

      • 14.3.1 Arcturus Therapeutics Inc Company Details

      • 14.3.2 Arcturus Therapeutics Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Arcturus Therapeutics Inc Transthyretin Product and Service

    • 14.4 Prothena Corp Plc

      • 14.4.1 Prothena Corp Plc Company Details

      • 14.4.2 Prothena Corp Plc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Prothena Corp Plc Transthyretin Product and Service

    • 14.5 Alnylam Pharmaceuticals Inc

      • 14.5.1 Alnylam Pharmaceuticals Inc Company Details

      • 14.5.2 Alnylam Pharmaceuticals Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Alnylam Pharmaceuticals Inc Transthyretin Product and Service

    • 14.6 Neurimmune Holding AG

      • 14.6.1 Neurimmune Holding AG Company Details

      • 14.6.2 Neurimmune Holding AG Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Neurimmune Holding AG Transthyretin Product and Service

    • 14.7 Pfizer Inc

      • 14.7.1 Pfizer Inc Company Details

      • 14.7.2 Pfizer Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Pfizer Inc Transthyretin Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Transthyretin

    • Figure Transthyretin Picture

    • Table Global Transthyretin Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Transthyretin Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Transthyretin Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Transthyretin Consumption by Country (2017-2022)

    • Figure United States Transthyretin Consumption and Growth Rate (2017-2022)

    • Table Europe Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure China Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Japan Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure India Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure South Korea Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Global Transthyretin Consumption Forecast by Country (2022-2028)

    • Figure United States Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AG-10 Consumption and Growth Rate (2017-2022)

    • Figure Global ALN-TTRsc02 Consumption and Growth Rate (2017-2022)

    • Figure Global CRX-1008 Consumption and Growth Rate (2017-2022)

    • Figure Global EDE-1307 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Familial Amyloid Neuropathies Consumption and Growth Rate (2017-2022)

    • Figure Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Cardomyopathy Consumption and Growth Rate (2017-2022)

    • Figure Global Neuropathy Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global AG-10 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ALN-TTRsc02 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CRX-1008 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global EDE-1307 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Familial Amyloid Neuropathies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardomyopathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neuropathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Transthyretin Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Transthyretin Export by Region (Top 5 Countries) (2017-2028)

    • Table Ionis Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Ionis Pharmaceuticals Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ionis Pharmaceuticals Inc Transthyretin Product and Service

    • Table Regeneron Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Inc Transthyretin Product and Service

    • Table Arcturus Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Arcturus Therapeutics Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arcturus Therapeutics Inc Transthyretin Product and Service

    • Table Prothena Corp Plc (Foundation Year, Company Profile and etc.)

    • Table Prothena Corp Plc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prothena Corp Plc Transthyretin Product and Service

    • Table Alnylam Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Alnylam Pharmaceuticals Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alnylam Pharmaceuticals Inc Transthyretin Product and Service

    • Table Neurimmune Holding AG (Foundation Year, Company Profile and etc.)

    • Table Neurimmune Holding AG Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurimmune Holding AG Transthyretin Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Transthyretin Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.